Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Carone

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Effects of isolated limb perfusion with tumor necrosis factor-alpha on circulating levels of proinflammatory cytokinesP Ferroni, F Di Filippo, F Martini, et al.
Anticancer Research|June 12, 1999
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancerA Spila, P Ferroni, M Cosimelli, et al.
Anticancer Research|June 9, 2001
Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluationA Spila, P Ferroni, M Cosimelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal studyF Guadagni, P Ferroni, S Carlini, et al.
Breast Cancer Research and Treatment|October 27, 2001
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancerR D'Alessandro, M Roselli, P Ferroni, et al.
Cancer Research|April 6, 2001
Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markersF Guadagni, J Kantor, S Aloe, et al.
European Journal of Neurology|September 28, 2020
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized noninferiority safety trialS Beretta, A Versace, B Martini, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Effects of isolated limb perfusion with tumor necrosis factor-alpha on circulating levels of proinflammatory cytokinesP Ferroni, F Di Filippo, F Martini, et al.
Anticancer Research|June 12, 1999
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancerA Spila, P Ferroni, M Cosimelli, et al.
Anticancer Research|June 9, 2001
Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluationA Spila, P Ferroni, M Cosimelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal studyF Guadagni, P Ferroni, S Carlini, et al.
Breast Cancer Research and Treatment|October 27, 2001
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancerR D'Alessandro, M Roselli, P Ferroni, et al.
Cancer Research|April 6, 2001
Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markersF Guadagni, J Kantor, S Aloe, et al.
European Journal of Neurology|September 28, 2020
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized noninferiority safety trialS Beretta, A Versace, B Martini, et al.
Pageof 2